JIM DAULTON: Open Payments
NPI 1538717319 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,009 in 142 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $2,214 · 2025 $5,009
Food & beverage: $3,189Travel & lodging: $1,801Education: $19
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $2,036 |
| ABBVIE INC. | 28 | $570 |
| Amgen Inc. | 24 | $486 |
| UCB, Inc. | 12 | $388 |
| Novartis Pharmaceuticals Corporation | 14 | $285 |
| Janssen Biotech, Inc. | 9 | $203 |
| Fresenius Kabi USA, LLC | 9 | $184 |
| Octapharma USA, Inc. | 3 | $152 |
| Mallinckrodt Hospital Products Inc. | 11 | $139 |
| ANI Pharmaceuticals, Inc. | 6 | $132 |
Products named: Bimzelx, RINVOQ, COSENTYX, KRYSTEXXA, SKYRIZI, TREMFYA, OCTAGAM IMMUNE GLOBULIN (HUMAN), ACTHAR.
Industry payments across AZ — which companies pay providers there.
